Sources checked October 21, 2026. Directory figures are from September 2026. This page explains terminology and published research; it does not diagnose symptoms or recommend a treatment.
Is atrophic vaginitis the same as GSM?
Atrophic vaginitis describes vaginal changes. GSM is broader: the 2014 terminology consensus includes changes involving the vulva, vagina, urethra and bladder associated with decreased estrogen and other sex steroids.[2]
The consensus lists genital dryness, burning and irritation; sexual discomfort and reduced lubrication; and urinary symptoms. It also specifies that another diagnosis should not better explain the symptoms.[2]
Lower estrogen is not limited to natural menopause. MedlinePlus also describes vaginal changes after ovary removal, some cancer treatments, childbirth and during breastfeeding.[1]
Does vaginal itching mean atrophic vaginitis?
Itching alone does not identify the cause. ACOG describes several forms of vaginitis, including yeast infection, bacterial vaginosis, trichomoniasis and atrophic vaginitis.[3]
The 2025 AUA/SUFU/AUGS guideline notes that there is no agreed number or combination of symptoms required for a GSM diagnosis. It also describes overlap between urinary symptoms and other urologic conditions.[4]
These distinctions matter when describing a concern at an appointment: a symptom, an examination finding and a diagnosis are different kinds of information. This page is not a self-diagnosis checklist.
How do clinicians evaluate vaginal symptoms?
The AUA/SUFU/AUGS guideline describes a focused medical, sexual and psychosocial history, a genitourinary examination, and assessment for coexisting conditions.[4]
ACOG explains that clinicians may test a vaginal discharge sample when evaluating vaginitis. Some results are available during the visit; others require laboratory processing.[3]
For an appointment, consider writing down when the symptoms began, where they occur, any urinary changes, and the medicines or vaginal products you use. Ask which findings support the diagnosis and whether another cause needs assessment. These are conversation prompts, not instructions to start or stop a product.
Which treatment terms might appear in a consultation?
The 2025 guideline discusses local vaginal estrogen, vaginal dehydroepiandrosterone (DHEA), oral ospemifene, moisturizers and lubricants as separate intervention categories.[4]
MedlinePlus lists vaginal estrogen presentations including cream, tablet, suppository and ring. It describes estrogen pills and skin patches separately.[1]
Ask for the exact product name and route rather than relying on the broad phrase hormone therapy. Ask whether a proposed product is intended for vaginal use or systemic use, what evidence is being cited, and who will assess follow-up. This guide does not select a product or provide a dose.
What have published trials measured?
The two examples below show how study populations, comparison groups and follow-up differ. They are selected trial summaries, not a systematic review or a treatment ranking.
What did the 2018 estradiol and moisturizer trial measure?
Mitchell and colleagues randomized 302 postmenopausal women with moderate to severe vulvovaginal symptoms to vaginal estradiol plus placebo gel, moisturizer plus placebo tablet, or dual placebo. The groups contained 102, 100 and 100 women. Follow-up was 12 weeks, and 294 women supplied data for the primary analysis.[5]
The primary outcome was change in the most bothersome symptom on a 0-to-3 severity scale. Mean changes were -1.4 with estradiol, -1.2 with moisturizer and -1.3 with placebo. The reported comparisons with placebo were not statistically significant: P=.25 and P=.31, respectively. These are findings from the specified preparations and study population, not a verdict about every vaginal product.[5]
What did the 2021 vaginal laser trial measure?
Li and colleagues conducted a randomized, sham-controlled trial in Sydney. The abstract reports 85 randomized postmenopausal women: 43 assigned to fractional carbon dioxide laser and 42 to sham treatment. Seventy-eight completed the 12-month follow-up.[6]
On the 0-to-100 overall vaginal symptom scale, where lower scores meant fewer symptoms, reported mean changes were -17.2 for laser and -26.6 for sham. The between-group comparison was not statistically significant. The study used one device protocol and does not establish outcomes for every device or individual.[6]
Where can I compare hormone therapy clinic listings?
Regenerated.com's September 2026 export contains 3,761 clinics listing HRT among 9,042 US clinic records, across all 50 states and Washington, DC. This is our directory's category coverage, not a count of clinicians confirmed to diagnose or treat atrophic vaginitis. Source: Regenerated.com clinic export, collected September 2026.
Use the HRT clinic directory to compare listings. For local browsing, see HRT clinics in Birmingham, Alabama and HRT clinics in Rogers, Arkansas. A listing is not an endorsement or a determination that hormone therapy suits your symptoms.
Before arranging a visit, ask whether the named clinician evaluates vulvovaginal and urinary symptoms, whether an examination is available, and which services require referral elsewhere. Request a written explanation of consultation charges and what is included. The directory does not confirm those details for an individual listing.